InMode designs, develops, manufactures and markets minimally-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radio frequency technologies. These technologies are used to remodel subdermal adipose, or fatty, tissue in a variety of procedures including liposuction with simultaneous skin tightening, body and face contouring and ablative skin rejuvenation treatments. In addition to the minimally-invasive technologies, Co. designs, develops, manufactures and markets non-invasive medical aesthetic products that target an array of procedures including permanent hair reduction, wrinkle reduction and cellulite treatment. The INMD stock yearly return is shown above.
The yearly return on the INMD stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2019 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the INMD annual return calculation with any dividends reinvested as applicable (on ex-dates).
|